Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression

被引:13
|
作者
de Arellano, Eva Ramirez
Martin, Cristina
Soriano, Vincent
Alcami, Jose
Holguin, Africa
机构
[1] Hosp Carlos 3, Dept Infect Dis, Madrid 28029, Spain
[2] Inst Salud Carlos 3, AIDS Immunopathogensis Unit, Majadahonda, Spain
关键词
HIV-1; long-term non-progressors; LTR; transcription; genetic variability;
D O I
10.1007/s11262-006-0054-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The long terminal repeat (LTR) region of HIV-1 promotes and modulates proviral transcription. LTR genetic variability might influence viral replication and disease progression. Proviral LTR sequences from 32 HIV-1-infected individuals showing different rates of disease progression were examined. Non-progressors (NP, n = 11) were individuals with high and stable CD4 counts and persistently low or undetectable plasma HIV-RNA. Slow progressors (SP, n = 6) were subjects with minimal CD4 decays over time and low plasma HIV-RNA. Typical progressors (TP, n = 15) were individuals with chronic infection showing CD4 counts repeatedly below 500 cells/mu l. The mutation frequency within distinct LTR functional regions involved in HIV-1 transcription were compared in these three groups of patients. No significant differences were observed in the mutation frequency in most LTR regulatory sites when comparing the three groups. However, changes in USF regulatory binding sites were more frequent in TP than in SP/NP, while changes in Sp1 binding sites were less common in the former. This is the first study examining the genetic variability of the HIV-1 LTR region in long-term non-progressors showing further divergent outcomes.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 50 条
  • [41] Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals
    Arab-Alameddine, M.
    Di Iulio, J.
    Buclin, T.
    Rotger, M.
    Lubomirov, R.
    Cavassini, M.
    Fayet, A.
    Decosterd, L. A.
    Eap, C. B.
    Biollaz, J.
    Telenti, A.
    Csajka, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (05) : 485 - 494
  • [42] Reduction of Serum Melatonin Levels in HIV-1-Infected Individuals’ Parallel Disease Progression: Correlation with Serum Interleukin-12 Levels
    G. Nunnari
    L. Nigro
    F. Palermo
    D. Leto
    R. J. Pomerantz
    B. Cacopardo
    Infection, 2003, 31 : 379 - 382
  • [43] Genetic signature analysis identifies the CD4i region of gp120 as a determinant of broadly NAb responses in HIV-1-infected individuals
    Gnanakaran, G.
    Bhattacharya, T.
    Daniels, M.
    Lapedes, A.
    Gao, F.
    Kumar, A.
    Li, M.
    Tang, H.
    Greene, K.
    Gao, H.
    Seaman, M.
    Haynes, B. F.
    Montefiori, D. C.
    Korber, B. T.
    RETROVIROLOGY, 2009, 6
  • [44] Reduction of serum melatonin levels in HIV-1-infected individuals' parallel disease progression: Correlation with serum interleukin-12 levels
    Nunnari, G
    Nigro, L
    Palermo, F
    Leto, D
    Pomerantz, RJ
    Cacopardo, B
    INFECTION, 2003, 31 (06) : 379 - 382
  • [45] GENETIC-CHARACTERIZATION OF THE HIV-1 LTR REGION OF LONG-TERM SURVIVORS
    ZHANG, LQ
    IP, J
    HUANG, YX
    HO, DD
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 214 - 214
  • [46] Genetic characterization of HIV type 1 long terminal repeat following vertical transmission
    Mehta, Roshni
    Ramakrishnan, Rajesh
    Doktor, Katherine
    Sundaravaradan, Vasudha
    Ahmad, Nafees
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (03) : 437 - 445
  • [47] Viral genetic heterogeneity in HIV-1-infected individuals is associated with increasing use of HAART and higher viremia
    Ross, L
    Johnson, M
    DeMasi, R
    Liao, QM
    Graham, N
    Shaefer, M
    St Clair, M
    AIDS, 2000, 14 (07) : 813 - 819
  • [48] Cocaine using HIV-1-infected African American individuals in the DREXELMED HIV/AIDS Genetic Analysis Cohort have altered immunomodulatory profiles
    Passic, S.
    Parikh, N.
    Dampier, W.
    Feng, R.
    Zhong, W.
    Aiamkitsumrit, B.
    Pirrone, V
    Nonnemacher, M. R.
    Jacobson, J.
    Wigdahl, B.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2014, 9 (01) : 44 - 44
  • [49] Can information measure be one of markers to estimate disease progression in HIV-1-infected patients?
    Sato, K
    Ohya, M
    OPEN SYSTEMS & INFORMATION DYNAMICS, 2001, 8 (02): : 125 - 136
  • [50] Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania
    Kupka, R
    Msamanga, GI
    Spiegelman, D
    Morris, S
    Mugusi, F
    Hunter, DJ
    Fawzi, WW
    JOURNAL OF NUTRITION, 2004, 134 (10): : 2556 - 2560